Predictors of complications after direct-to-implant breast reconstruction with an acellular dermal matrix from a multicentre randomized clinical trial
Authors:
Open Access
- 16 April 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 105 (10) , 1305-1312
Abstract
Background: In the multicentre randomized trial BRIOS (Breast Reconstruction In One Stage), direct-to-implant (DTI) breast reconstruction with an acellular dermal matrix (ADM) was associated with a markedly higher postoperative complication rate compared with two-stage tissue expander/implant breast reconstruction. This study aimed to identify factors that contribute to the occurrence of complications after DTI ADM-assisted breast reconstruction. Methods: Data were obtained from the BRIOS study, including all patients treated with DTI ADM-assisted breast reconstruction. Logistic regression analyses were performed to identify factors predictive of postoperative complications. Results: Fifty-nine patients (91 breasts) were included, of whom 27 (35 breasts) developed a surgical complication. Reoperations were performed in 29 breasts (32 per cent), with prosthesis removal in 22 (24 per cent). In multivariable analyses, mastectomy weight was associated with complications (odds ratio (OR) 1·94, 95 per cent c.i. 1·33 to 2·83), reoperations (OR 1·70, 1·12 to 2·59) and removal of the implant (OR 1·55, 1·11 to 2·17). Younger patients (OR 1·07, 1·01 to 1·13) and those who received adjuvant chemotherapy (OR 4·83, 1·15 to 20·24) more frequently required reoperation. In univariable analyses, adjuvant radiotherapy showed a trend towards more complications (OR 7·23, 0·75 to 69·95) and removal of the implant (OR 5·12, 0·76 to 34·44), without reaching statistical significance. Conclusion: Breast size appeared to be the most significant predictor of complications in DTI ADM-assisted breast reconstruction. The technique should preferably be performed in patients with small to moderate sized breasts. Registration number: NTR5446 (http://www.trialregister.nl).Keywords
Funding Information
- Pink Ribbons Project
- Nuts-Ohra
- Life Cell Corporation
This publication has 32 references indexed in Scilit:
- Acellular dermal matrix (ADM) assisted breast reconstruction proceduresEuropean Journal of Surgical Oncology, 2013
- Acellular Dermal Matrices in Abdominal Wall ReconstructionPlastic and Reconstructive Surgery, 2012
- Intraoperative Perfusion Techniques Can Accurately Predict Mastectomy Skin Flap Necrosis in Breast ReconstructionPlastic and Reconstructive Surgery, 2012
- A Systematic Review and Meta-Analysis of Complications Associated With Acellular Dermal Matrix-Assisted Breast ReconstructionAnnals of Plastic Surgery, 2012
- Use of human acellular dermal matrix in implant- based breast reconstruction: Evaluating the evidenceJournal of Plastic, Reconstructive & Aesthetic Surgery, 2011
- Retrospective Review of 331 Consecutive Immediate Single-Stage Implant Reconstructions with Acellular Dermal MatrixPlastic and Reconstructive Surgery, 2011
- Total Skin-Sparing MastectomyAnnals of Surgery, 2009
- What is a large breast? Measuring and categorizing breast size for tangential breast radiation therapyAustralasian Radiology, 2007
- Infection in breast implantsThe Lancet Infectious Diseases, 2005
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003